Safety and Effectiveness of Overripe Banana Powder Added to Diabetic Formulas in Type 2 Diabetes
Safety and Effectiveness of Overripe Banana Powder Added to Diabetic Formulas in Type 2 Diabetes
NCT ID: NCT07471607 Phase: NA Status: COMPLETED Enrollment: 60 Completion: 2025-09-30
Conditions
Type 2 Diabetes, Metabolic Disorders
Interventions
Overripe Banana Powder Formulation, Standard Nutritional Formulation
Summary
This randomized controlled clinical trial aims to evaluate the effects of overripe banana powder supplementation on metabolic parameters among patients with type 2 diabetes mellitus (T2DM). Dietary management plays a crucial role in glycaemic control for individuals with T2DM, and the identification of functional food ingredients with potential metabolic benefits has gained increasing research interest. Overripe banana contains various bioactive compounds including resistant starch, dietary fiber, and polyphenols, which may contribute to improved glycaemic regulation and metabolic outcomes.
Participants diagnosed with T2DM will be randomly assigned to receive either a nutritional intervention or control supplementation for a defined intervention period. The intervention involves daily consumption of a measured dose of overripe banana powder incorporated into the participants' diet. Clinical and biochemical parameters will be assessed at baseline and after the intervention period to evaluate potential metabolic changes.
Primary outcomes include indicators of glycaemic control such as fasting blood glucose and glycated hemoglobin (HbA1c). Secondary outcomes include changes in blood pressure and other metabolic parameters. The findings of this study may provide evidence on the potential role of overripe banana-derived functional ingredients as a dietary strategy for improving metabolic health among individuals with T2DM.
Primary Outcome
Fasting blood glucose (mmol/L)